PerkinElmer sells IDS unit for $500M

PerkinElmer has agreed to sell its Illumination and Detection Solutions business to PE firm Veritas Capital Fund III for $500 million in cash ($482 million net of payment for acquired cash balances). The 3,000-employee unit, which includes 14 manufacturing facilities, provides lighting and sensor components, subsystems and integrated solutions to equipment manufacturers serving a various health, environmental and security segments. The business is expected to generate $300 million in 2010 revenue.

PerkinElmer's President and CEO Robert Friel says the sale reduces the company's complexity and frees up capital to invest in human and environmental health markets. "[T]his transaction should reduce the company's exposure to more cyclical end markets and improve our top-line growth profile. Furthermore, we would expect adjusted gross margins to improve by over 200 basis points, contributing to higher earnings growth."

- read PerkinElmer's release
- check out the Mass High Tech article

Suggested Articles

The immunoassay will measure neurofilament light chain protein levels, found in the blood and cerebrospinal fluid, and linked to nerve damage.

Emmecell aims to make corneal transplant surgery, which can take up to a year to heal from and fails up to 20% of the time, a relic of the past.

Seven developers will provide digital health solutions aimed at the COVID-19 pandemic, including smartphone apps, wearables and big data programs.